Fábio Teixeira is a biologist that performed his PhD in Health Sciences at the Life and Health Sciences Research Institute (ICVS), School of Medicine and ICVS/3B’s PT Government Associate Laboratory Braga/Guimarães, University of Minho. His PhD project consisted in the development of new strategies through the use of Mesenchymal Stem Cells (MSCs) and their Secretome as a new possible therapeutic strategy for the regeneration of central nervous system (CNS), in collaboration with the Pharmaceutical Production Research Facility (PPRF), University of Calgary, Canada. Currently, he is a Junior Principal Investigator at the Life and Health Sciences Research Institute (ICVS) – University of Minho. His research interests are focused in the development of new and innovative strategies for Parkinson’s Disease (PD) repair, namely by the exploration of combinatorial approaches using MSCs secretome and (new) pharmacological strategies used for the treatment of PD. Still, he has also been involved in the design and development of clinical studies, namely in the 1) derivation of inducible pluripotent stem cells (iPSCs) from PD patients, 2) exploitation of (new) potential biomarkers for PD both in animal models and human patients, and in the 3) assessment of the effects of new PD drugs on gait and functional brain network of PD patients.